Pacira BioSciences, Inc. (PCRX)
USD 19.19
(-3.23%)
USD 19.19
(-3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 674.97 Million | 666.82 Million | 541.53 Million | 420.83 Million | 421.02 Million | 337.27 Million |
| Cost of Revenue | 184.66 Million | 199.29 Million | 140.25 Million | 117.32 Million | 106.71 Million | 86.84 Million |
| Gross Profit | 490.3 Million | 467.52 Million | 401.27 Million | 303.5 Million | 314.31 Million | 250.43 Million |
| Operating Expenses | 326.37 Million | 396.6 Million | 268.44 Million | 260.8 Million | 278.6 Million | 232.95 Million |
| Selling, General and Administrative Expenses | 269.44 Million | 254.51 Million | 199.34 Million | 193.51 Million | 200.78 Million | 177.26 Million |
| Research and Development Expenses | 76.25 Million | 84.79 Million | 55.54 Million | 59.42 Million | 72.11 Million | 55.68 Million |
| Other Expenses | 241.6 Million | 57.28 Million | 13.55 Million | 7.86 Million | 5.7 Million | -888 Thousand |
| Cost and Expenses | 587.3 Million | 595.89 Million | 408.69 Million | 378.13 Million | 385.31 Million | 319.79 Million |
| Operating Income | 87.67 Million | 60.02 Million | 131.06 Million | 46.35 Million | 38.11 Million | 15.91 Million |
| Interest Expense | 20.3 Million | 39.97 Million | 31.75 Million | 25.67 Million | 23.62 Million | 21.94 Million |
| Income Tax Expense | 19.74 Million | -2.6 Million | 14.42 Million | -125.43 Million | 268 Thousand | 46 Thousand |
| Earnings before Tax | 61.7 Million | 13.3 Million | 56.4 Million | 20.08 Million | -10.74 Million | -425 Thousand |
| Net Income | 41.95 Million | 15.9 Million | 41.98 Million | 145.52 Million | -11.01 Million | -471 Thousand |
| Earnings Per Share Basic | 0.91 | 0.35 | 0.95 | 3.41 | -0.27 | -0.01 |
| Earnings Per Share Diluted | 0.81 | 0.34 | 0.92 | 3.33 | -0.27 | -0.01 |
| Weighted Average Shares Outstanding | 46.22 Million | 45.52 Million | 44.26 Million | 42.67 Million | 41.51 Million | 40.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.97 Million | 46.53 Million | 45.63 Million | 43.68 Million | 41.51 Million | 40.91 Million |
| Gross Margin | 0.73 | 0.70 | 0.74 | 0.72 | 0.75 | 0.74 |
| EBIT Margin | 0.24 | 0.18 | 0.27 | 0.16 | 0.10 | 0.07 |
| Profit Margin | 0.06 | 0.02 | 0.08 | 0.35 | -0.03 | -0.00 |
| EBITDA | 162.89 Million | 144.77 Million | 118.47 Million | 71.42 Million | 55.28 Million | 33.05 Million |
| Earnings Before Tax Margin | 0.13 | 0.09 | 0.24 | 0.11 | 0.09 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 178.02 Million | 167.11 Million | 181.24 Million | 674.97 Million | 163.92 Million | 169.46 Million |
| Cost of Revenue | 58.58 Million | 61.73 Million | 62.01 Million | 241.95 Million | 39.75 Million | 48.2 Million |
| Gross Profit | 119.43 Million | 105.37 Million | 119.23 Million | 433.02 Million | 124.17 Million | 121.26 Million |
| Operating Expenses | 88.46 Million | 90.26 Million | 85.26 Million | 345.69 Million | 103.09 Million | 97.99 Million |
| Selling, General and Administrative Expenses | 68.12 Million | 72.02 Million | 65.8 Million | - | 67.94 Million | 64.85 Million |
| Research and Development Expenses | 20.33 Million | 18.23 Million | 19.46 Million | - | 20.83 Million | 18.82 Million |
| Other Expenses | -39 Thousand | -159 Thousand | 515 Thousand | -186 Thousand | -422 Thousand | -269 Thousand |
| Cost and Expenses | 147.04 Million | 152 Million | 147.27 Million | 587.65 Million | 142.84 Million | 146.2 Million |
| Operating Income | 30.97 Million | 15.11 Million | 33.96 Million | 87.32 Million | 17.72 Million | 39.87 Million |
| Interest Expense | 3.12 Million | 2.63 Million | 4.09 Million | 23.8 Million | 3.46 Million | 3.86 Million |
| Income Tax Expense | 17.69 Million | 4.66 Million | 8.85 Million | 19.74 Million | 5.74 Million | 12.09 Million |
| Earnings before Tax | 36.58 Million | 13.64 Million | 33.72 Million | 61.7 Million | 16.6 Million | 37.85 Million |
| Net Income | 18.88 Million | 8.97 Million | 24.87 Million | 41.95 Million | 10.85 Million | 25.76 Million |
| Earnings Per Share Basic | 0.41 | 0.19 | 0.54 | - | 0.23 | 0.56 |
| Earnings Per Share Diluted | 0.39 | 0.19 | 0.48 | - | 0.23 | 0.49 |
| Weighted Average Shares Outstanding | 46.17 Million | 46.49 Million | 46.43 Million | 46.22 Million | 46.41 Million | 46.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.53 Million | 52.19 Million | 52.06 Million | 51.97 Million | 52.06 Million | 52.05 Million |
| Gross Margin | 0.67 | 0.63 | 0.66 | 0.64 | 0.76 | 0.72 |
| EBIT Margin | 0.28 | 0.20 | 0.29 | - | 0.23 | 0.23 |
| Profit Margin | 0.11 | 0.05 | 0.14 | 0.06 | 0.07 | 0.15 |
| EBITDA | 49.83 Million | 33.54 Million | 52.45 Million | - | 37.74 Million | 39.42 Million |
| Earnings Before Tax Margin | 0.17 | 0.09 | 0.19 | 0.13 | 0.11 | 0.24 |
096770
ADCON
8079
RITM-PC
300069
2022